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highly bizarre forms they can 
take. 
Rob Kesseler is a professor 
at Central Saint Martins 
College of Art and Design. 
He has had a long career of 
working with plants as a source 
of inspiration for his work and, 
since 2001, he has been working 
at Kew with microscopic plant 
material.
The inspiration for the new 
book comes from the role that 
fruits and seeds play in the 
survival of each species, which 
explains the many dispersal 
mechanisms that plants have 
developed during evolution. The 
strategies they take, whether 
they involve wind, water, humans 
and animals or the plant’s own 
explosive triggers, are reflected 
in the vast range of different 
colours, sizes and shapes — 
some edible, some inedible and 
others just bizarre.
The authors have used 
a variety of approaches to 
produce the illustrations in 
the book. Scanning electron 
microscopy has been used 
to capture some of the forms 
while cross-sections reveal 
intricate interiors, berries and 
pods, nuts and other examples 
of botanical architecture 
and reproductive ingenuity. 
Black and white microscopic 
images have been coloured by 
Kesseler to highlight structure 
and function within the fruits that 
are almost too miniscule to be 
seen by the naked eye. Larger 
fruits, their flowers and some 
of their animal dispersers have 
been specially photographed 
for the book to produce a 
total of more than 250 colour 
illustrations.
The formation, development 
and demise of the fruits are 
described by Stuppy, who 
explains their vital role in the 
preservation and biodiversity of 
the planet.
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Jeannie T. Lee is an Investigator 
of the Howard Hughes Medical 
Institute and Professor of Genetics 
(and Pathology) at Harvard Medical 
School and the Massachusetts 
General Hospital. She was 
an undergraduate at Harvard 
University where she majored 
in Biochemistry and Molecular 
Biology, and worked with Nancy 
Kleckner on the control of Tn10 
transposition by antisense RNA. She 
then obtained M.D.-Ph.D degrees 
from the University of Pennsylvania 
School of Medicine, where she 
became interested in epigenetic 
regulation of human disease 
while a dissertation student with 
Robert L. Nussbaum. Afterwards, 
she trained briefly in Clinical 
Pathology at the Massachusetts 
General Hospital, before joining 
Rudolf Jaenisch at the Whitehead 
Institute as a postdoctoral fellow. 
Since she became independent 
in 1997, her lab’s interests have 
included X-inactivation, imprinting, 
the emerging link between 
noncoding RNA and chromatin 
control, and the evolutionary 
history of sex chromosomes and 
dosage compensation. She is 
also passionately interested in the 
interaction between environment 
and genome and imagines pursuing 
this during the next stage of her 
career. She has received the Basil 
O’Connor Scholar Award from 
the March of Dimes and the Pew 
Scholars Award from the Pew 
Foundation. Currently, she serves 
on NIH study section (grant review 
panel), is an Associate Editor for the 
Public Library of Science (Genetics), 
and is co-organizing the next Gordon 
Conference in Epigenetics.
What turned you onto science? 
I was sure that I would become a 
physician, but then I took a major 
in physics and chemistry in college. 
In my sophomore year, I had an 
epiphany: after a lecture course by 
Mark Ptashe, Tom Maniatis, and 
Doug Melton, I realized I ought 
to be in molecular biology. After 
one semester in the Kleckner lab, 
however, Nancy told me I had to 
Q & A work harder and think better. I tried. A career in basic science was not 
an obvious substitute for medicine. 
But soon I learned that experimental 
discovery is one of the most 
rewarding experiences in life.  
Twenty years later, I am a basic 
scientist — still working on 
noncoding RNA — and still getting 
that high out of science.
What attracted you to 
X- inactivation? It was easy to fall in 
love with this problem — everything 
about it is like a great detective story. 
In Bob Nussbaum’s lab as a PhD 
student, I was already well aware of 
the mystery, but not until I heard the 
XIST story from Hunt Willard’s group 
did I think seriously about working 
on it.  XIST encodes an untranslated 
RNA that shows the reverse pattern 
of expression from all other X-linked 
genes in female mammals – The 
RNA is expressed only from the 
‘inactive’ X and spreads all over that 
chromosome to form an RNA blanket. 
An RNA that sticks to a chromosome 
and regulates its gene expression 
was just too interesting to pass up! 
Rudolf’s lab was a great place to test 
the ideas in mice, so that is where 
I got my start in X-inactivation. In 
Rudolf’s lab, I transplanted a 450 
kilobase region of the X-inactivation 
center to an autosome and found that 
it can serve as a silencing center at 
the ectopic location. This discovery 
gave me the start I needed to identify 
new regulatory elements in my own 
lab. The transgene analysis paved the 
way for the discovery of Tsix and Xite.
If you could do it all over again, 
would you choose the same career 
path? This is the best job in the 
world. Sometimes (only sometimes) 
I think I might skip medical school 
next time around. I was not a natural 
medical student, but I learned many 
things that are put into daily practice 
in a non-obvious way. For example, 
mouse embryology is much easier 
when one has been taught human 
anatomy and physiology. Applying 
concepts in X-inactivation and 
epigenetics to human health also 
comes much more easily. Although 
my lab has focused exclusively on 
basic science up to this point, I have 
not abandoned plans for medicine at 
all. My plan is to link epigenetics to 
human disease during the next stage 
of my career. I have recently steered 
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Tight junctions
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What is a tight junction? Tight 
junctions (TJs) are intercellular contacts 
that seal the space between the 
individual cells of an epithelial sheet 
so that they can collectively separate 
tissue compartments. The barrier 
is required to accomplish vectorial 
transport of material from one side of 
the compartment to the other and to 
limit paracellular entry of undesirables 
like toxins, antigens and microbes. 
The tight junction forms a continuous 
intercellular contact at the apical-most 
end of the lateral side of epithelial cells 
(Figure 1), above other specialized 
cell contacts like adherens and gap 
junctions and desmosomes. Its name 
derives from early transmission electron 
microscopy images showing membrane 
‘kiss points’ between adjacent cells 
where the outer membrane leaflets 
appeared to fuse. It is also called the 
occluding junction (OJ) and the zonula 
occludens (ZO). TJs do not just act as 
barriers but are also sites for vesicle 
targeting, cytoskeletal dynamics, 
signals controlling proliferation and 
transcription, and for defining cellular 
polarity between the functionally 
distinct apical and lateral membrane 
surfaces.
What are TJs made of? Compared 
with other junctions, TJs include a 
surprisingly large number of different 
proteins — at least 40. The actual 
barrier is formed by continuous 
adhesive strands of transmembrane 
proteins that interact to seal the 
paracellular space (Figure 1). These 
transmembrane proteins are called 
claudins and form the hallmark network 
of interconnected strands revealed 
by freeze–fracture EM. Many different 
claudins are often expressed in a single 
cell and their expression profiles create 
the variations in barrier properties 
observed among different tissues. 
Other adhesion proteins collect in 
the strands but their function remains 
unclear; these include tricellulin (which 
tends to concentrate where three 
cells come together), its homolog 
occludin and an immunoglobulin 
Quick guidepart of my lab in that direction with work on human embryonic stem cells 
which, as we have come to learn, 
show aberrant epigenetic regulation. 
There is a lot to learn from this much 
needed human model.
What do you enjoy most about 
science? The challenge, the 
discovery, and the people. In this 
profession, one meets some of 
the brightest (and most eccentric) 
minds on Earth. Although I dislike 
airports and flying, I do enjoy the 
chance to see different cultures, 
experience science as it is done in 
other countries, and taste great food 
(I always enjoy myself once I am 
there). Through science, one has the 
chance to make a lasting positive 
contribution to our society and 
planet.
Are there any disappointments in 
science? For me, one of the biggest 
attractions to science is that it is 
inherently value-free. There is one 
truth that cannot be changed by 
culture, history, and politics. But I no 
longer think that science is devoid of 
politics. Science itself is objective, 
but the practice of it is about people, 
personalities, and perceptions of 
what is important. We see this in 
the way grants are awarded, papers 
published, and policies established 
by the government. I see great 
ideas that are not given a chance at 
being tested because of diminishing 
resources; or great ideas not finding 
an appropriate place in the literature 
because of a general unwillingness 
to take risks on very imaginative 
thinking. Perhaps there is no way 
around this, especially with the 
current crisis in grant funding. Both 
junior and seasoned investigators 
spend a lot of time writing grants to 
keep their laboratories alive when 
their time would be more productively 
spent on experiments.
Any career advice for someone 
just starting their own lab? Stay 
at the bench for as long as possible, 
because it is more rewarding to 
do experiments than to exercise 
your administrative skills in the 
office. Nowadays, I am more coach, 
cheerleader, and psychologist than 
experimentalist — sadly. The people 
you hire are your greatest assets — 
choose and treat them well. Hire 
people with complementary skills and always try to keep a balance of talent 
and personalities in the lab. Over the 
years, I have come to value talent, 
work ethic, honesty, and collaborative 
spirit equally.
Are there gender differences in 
science? As someone who makes a 
living out of studying male and female 
differences, you might think that I am 
hardwired to think so! But I am not a 
big proponent of the idea that men 
and women inherently do science 
differently. Whatever difference there 
is, I am certain that there are many 
more differences among individuals 
and cultures than between the sexes. 
This I see in practice everyday. From 
what I can see in my own lab, there is 
not a significant ‘delta’ in work hours, 
talent, and commitment.
What emerging problems 
interest you most? There are so 
many problems I would work on 
now. If I were a student thinking 
about science, I might focus on 
environmental issues, energy, 
neurobiology, or cognitive science.  
I also think that the areas of  
genome–environment interactions 
and environmental toxicology 
(branches of epigenetics) will 
blossom in the coming years.
What would you like to see solved 
in the next 10 years? An end to 
global warming and pollution. I 
would also like to see better land 
stewardship and conservation. Do 
you think I’m unrealistic?
What advice would you give a 
student thinking about a career 
in academic science? You must 
love it — everything about it, from 
writing and speaking to thinking 
and doing. As with anything else in 
life, it is easier to love something 
when you are good at it. So find a 
problem that suits your talent and 
personal goals. Expect no immediate 
rewards (money, fame, prizes). If 
you are passionate about science, 
you will survive grant writing, paper 
rejections, and the long road to 
tenure. A life in science is one of the 
best there is.
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